Catalyst Wire Dossier Catalyst Wire Dossier

Vyvgart (efgartigimod)

efgartigimod · argenx
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vyvgart (efgartigimod), covering 2025-03-30 to 2025-03-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) [Phase 3]

See pricing